Abstract
First discovered two decades ago through genetic screens in Drosophila, the Hippo pathway has been shown to be conserved in metazoans and controls organ size and tissue homeostasis through regulating the balance between cell proliferation and apoptosis. Dysregulation of the Hippo pathway leads to aberrant tissue growth and tumorigenesis. Extensive studies in Drosophila and mammals have identified the core components of Hippo signaling, which form a central kinase cascade to ultimately control gene expression. Here, we review recent structural, biochemical, and cellular studies that have revealed intricate phosphorylation-dependent mechanisms in regulating the formation and activation of the core kinase complex in the Hippo pathway. These studies have established the dimerization-mediated activation of the Hippo kinase (mammalian Ste20-like 1 and 2 (MST1/2) in mammals), the dynamic scaffolding and allosteric roles of adaptor proteins in downstream kinase activation, and the importance of multisite linker autophosphorylation by Hippo and MST1/2 in fine-tuning the signaling strength and robustness of the Hippo pathway. We highlight the gaps in our knowledge in this field that will require further mechanistic studies.
Highlights
The Hippo pathway controls cell numbers and organ size in multicellular organisms through restricting cell growth and proliferation and promoting apoptosis
The timely release of Mammalian Ste20-like 1 and 2 (MST1/2) from pMOB1 could facilitate MST1/2 binding to multiple Mps One Binder 1 (MOB1) proteins to enhance the kinase activation of Large Tumor Suppressor 1 and 2 (LATS1/2) and/or facilitate Yes-associated protein (YAP)/transcriptional co-activator with PDZ-binding motif (TAZ) binding to the pMOB1–LATS1/2 complex during Hippo signaling
MST1/2 autoactivation requires two kinase domains to be in close proximity for efficient trans-autophosphorylation, SAV1 and MST2 only form a heterodimer through the SARAH interaction
Summary
The Hippo pathway controls cell numbers and organ size in multicellular organisms through restricting cell growth and proliferation and promoting apoptosis. When the Hippo pathway is turned on, the upstream MST1/2 kinases in complex with SAV1 phosphorylate and activate the LATS1/2–MOB1 complexes. The timely release of MST1/2 from pMOB1 could facilitate MST1/2 binding to multiple MOB1 proteins to enhance the kinase activation of LATS1/2 and/or facilitate YAP/TAZ binding to the pMOB1–LATS1/2 complex during Hippo signaling.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.